Clinical Trial Update: dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma [NA]

View source ↗

Summary

A clinical trial is currently recruiting to evaluate the combination of dTACE-HAIC with bevacizumab and atezolizumab for advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Advanced Hepatocellular Carcinoma, Atezolizumab | NA | Status: RECRUITING